Filing Flows › AtriCure (ATRC) › Recalls, complaints & regulation
AtriCure (ATRC): recalls and clinical trials
AtriCure (ATRC) beyond its filings: 0 recalls in the last 12 months (2 in five years, 0 Class I); 9 active clinical trials.
Latest recalls
- 2024-02-07 · FDA device · Cryo Module Accessories Domestic CMA-OUS, Product Catalog Number A001053
- 2024-02-07 · FDA device · Packaged, Tank Hose Assembly CMA-US, Product Catalog Number A001056
AtriCure's latest quarter
AtriCure, Q3 2026: revenue $154M (+15% year over year), operating margin 2.8%, net earnings $4.1M, operating cash flow $30.3M. The chart follows the revenue to costs, profit and cash.
Questions
Has AtriCure had any recalls?
2 recalls on file over five years from the FDA, CPSC and NHTSA; 0 in the last 12 months.
How many clinical trials does AtriCure have?
9 active studies on ClinicalTrials.gov, 0 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.